Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Neuroblastoma × Vorinostat × Clear all

Status

Completed 5 Unknown 2 Recruiting 1 Not yet recruiting 1 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Pheochromocytoma 1 Paraganglioma 1 Neuroblastoma 1

Interventions

3-Iodobenzylguanidine 2 pegfilgrastim 1 omburtamab I-131 1 fluorodopa F 18 1 Vorinostat 1 Potassium Iodide 1 Ketoconazole 1 Granulocyte Colony-Stimulating Factor 1 Fenretinide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01838187 2023-08-18

Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma

Children's Hospital Medical Center, Cincinnati

No longer available

Neuroblastoma, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡